"vascular endothelial growth factor inhibitor" trang 4 - tải miễn phí từ tailieunhanh
Positive prognostic value of HER2-HER3 coexpression and p-mTOR in gastric cancer patients

Positive prognostic value of HER2-HER3 coexpression and p-mTOR in gastric cancer patients
16    67    1
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
11    77    1
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
10    71    1
RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis

RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis
4    74    1
Effective treatment of apatinib in desmoplastic small round cell tumor: A case report and literature review

Effective treatment of apatinib in desmoplastic small round cell tumor: A case report and literature review
6    73    1
Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2

Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2
12    62    1
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
13    31    1
A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen
8    40    1
Pazolimus: Pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis

Pazolimus: Pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis
8    47    1
Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels

Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels
10    91    1
Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival

Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival
12    28    1
A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities
12    44    1
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
7    39    1
Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study
10    44    1
Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity

Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity
11    34    1
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis

Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
15    35    1
Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype
6    23    1
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study
10    37    1
Serum soluble ST2 is associated with ER-positive breast cancer

Serum soluble ST2 is associated with ER-positive breast cancer
8    28    1
Interplay between 3′-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans

Interplay between 3′-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans
10    42    1